Young Il Chung, DO
Family Medicine · Brookhaven, GANPI 1730765595
Payments from drug & device makers
Across 85 payments — averaging $21.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$249
- Pfizer$226
- Sanofi-aventis U.S. LLC$211
- Lilly USA, LLC$127
- Axsome Therapeutics, Inc.$125
- AstraZeneca$115
- plus $788 from 17 others
What the payments were for
- Food & beverage$1,841100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 8 | $249 |
| Pfizer | 11 | $226 |
| Sanofi-aventis U.S. LLC | 8 | $211 |
| Lilly USA, LLC | 6 | $127 |
| Axsome Therapeutics, Inc. | 5 | $125 |
| AstraZeneca | 6 | $115 |
| Astellas Pharma US Inc | 4 | $108 |
| AbbVie | 7 | $105 |
| Boehringer Ingelheim | 4 | $81 |
| Novo Nordisk | 3 | $58 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $56 |
| Phathom Pharmaceuticals, Inc. | 3 | $51 |
| Otsuka America Pharmaceutical, Inc. | 2 | $49 |
| Abbott | 2 | $44 |
| Exact Sciences | 2 | $36 |
| Novartis | 2 | $34 |
| Acadia Pharmaceuticals Inc | 1 | $32 |
| Merck | 2 | $30 |
| Currax Pharmaceuticals LLC | 2 | $28 |
| Inspire Medical Systems, Inc. | 1 | $25 |
| GSK | 1 | $22 |
| Dexcom, Inc. | 1 | $20 |
| Dynavax Technologies Corporation | 1 | $11 |
How this compares
$1,841 in reported general payments places this provider in the 65th percentile of 3,111 family medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 15 | $391 |
| Amlodipine Besylate | 39 | $251 |
| Rosuvastatin Calcium | 25 | $207 |
| Losartan Potassium | 31 | $199 |
| Atorvastatin Calcium | 29 | $184 |
| Metformin Hcl | 18 | $142 |
| Gabapentin | 18 | $108 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Brookhaven
- Joseph SurberColumbus$16.6M
- Angela RitterGainesville$15.8M
- Jeffrey KingsleyColumbus$8.1M
- Christopher OldfieldSavannah$6.4M
- Darrell MurrayAtlanta$3.9M
- Ben ThomasAtlanta$3.2M
- Debbie HaginsSavannah$2.1M
- Aziz PiraniLilburn$2.1M
- Nadia CameronAtlanta$2.1M
- John LentzSnellville$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.